MGRN1 and melanoma: Consistent with this finding, we showed previously that abrogation of MGRN1 expression in mouse melanocytes and B16 mouse melanoma cells by CRISPR/Cas9 led to a more dendritic and differentiated phenotype with higher melanin content [26].